BMC Remedy Mid Tier 9.1SP3 is affected by remote and local file inclusion. Due to the lack of restrictions on what can be targeted, the system can be vulnerable to attacks such as system fingerprinting, internal port scanning, Server Side Request Forgery (SSRF), or remote code execution (RCE).
Conclusion & alert: CVE-2017-17674 is rated High Risk (67.6/100): CVSS Critical severity, with medium exploitation likelihood (EPSS 2.57%). Mandatory action: High exploitation likelihood—assess exposure and prioritize remediation.
Risk is dynamic; we continuously reassess and refresh what is shown on this page as upstream context changes.
EPSS lead: Daily EPSS estimates relative likelihood of exploitation; percentile ranks this CVE among scored vulnerabilities (higher = more severe relative rank).
| # | Date | Old EPSS score | New EPSS score | Delta (New - Old) |
|---|---|---|---|---|
| 1 | 2026-06-15 | 3.28% | 2.57% | -0.71% |
| 2 | 2025-03-30 | 10.43% | 3.28% | -7.15% |
| 3 | 2025-03-29 | — | 10.43% | — |
Full EPSS history (11 records total)
CVSS metrics for this CVE.
| Base score | Version | Severity | Vector | Exploitability | Impact | Score source |
|---|---|---|---|---|---|---|
| 9.8 | 3.1 | CRITICAL |
|
3.9 | 5.9 | [email protected] |
| 7.5 | 2.0 | HIGH |
|
10.0 | 6.4 | [email protected] |
| Vendor | Product | Version | Raw CPE |
|---|---|---|---|
| bmc | remedy_mid-tier | 9.1 | cpe:2.3:a:bmc:remedy_mid-tier:9.1:sp3:*:*:*:*:*:* |
| URL | Tags |
|---|---|
| http://bmc.com | Product |
| http://remedy.com | Product |
| https://docs.bmc.com/docs/ars91/en/9-1-00-fixes-available-for-remedy-ar-system-security-vulnerabilities-800555806.html | Release Notes Vendor Advisory |
| https://seclists.org/fulldisclosure/2017/Oct/52 | Mailing List Third Party Advisory |